3D-printing and the effect on medical costs: a new era?

被引：132

作者：

Choonara, Yahya E. ^{[1
]}

du Toit, Lisa C. ^{[1
]}

Kumar, Pradeep ^{[1
]}

Kondiah, Pierre P. D. ^{[1
]}

Pillay, Viness ^{[1
]}

机构：

[1] Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Dept Pharm & Pharmacol,Wits Adv Drug Delivery Pla, 7 York Rd, ZA-2193 Parktown, South Africa

来源：

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH | 2016年 / 16卷 / 01期

基金：

新加坡国家研究基金会;

关键词：

3D-printing; medical device; pharmaceuticals; biotechnology; medical costs; innovative healthcare; additive manufacturing; virtual pharmacies; developing economies; bioprinting; HYDROGEL SCAFFOLDS; 3-D PRINTERS; DRUG-RELEASE; 3D; FABRICATION; TABLETS; SPINE;

D O I：

10.1586/14737167.2016.1138860

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

100404 [儿少卫生与妇幼保健学];

摘要：

3D-printing (3DP) is the art and science of printing in a new dimension using 3D printers to transform 3D computer aided designs (CAD) into life-changing products. This includes the design of more effective and patient-friendly pharmaceutical products as well as bio-inspired medical devices. It is poised as the next technology revolution for the pharmaceutical and medical-device industries. After decorous implementation scientists in collaboration with CAD designers have produced innovative medical devices ranging from pharmaceutical tablets to surgical transplants of the human face and skull, spinal implants, prosthetics, human organs and other biomaterials. While 3DP may be cost-efficient, a limitation exists in the availability of 3D printable biomaterials for most applications. In addition, the loss of skilled labor in producing medical devices such as prosthetics and other devices may affect developing economies. This review objectively explores the potential growth and impact of 3DP costs in the medical industry.

引用

页码：23 / 32

页数：10

共 58 条

[1]

[Anonymous], 2013, Science, V342, P439

[2]

[Anonymous], 2009, EUR RADIOL

[3]

[Anonymous], 2014, Fin24

[4]

High-strength porous biomaterials for bone replacement: A strategy to assess the interplay between cell morphology, mechanical properties, bone ingrowth and manufacturing constraints [J].